NO883127L - Heling av saar og regenerering av ben. - Google Patents

Heling av saar og regenerering av ben.

Info

Publication number
NO883127L
NO883127L NO883127A NO883127A NO883127L NO 883127 L NO883127 L NO 883127L NO 883127 A NO883127 A NO 883127A NO 883127 A NO883127 A NO 883127A NO 883127 L NO883127 L NO 883127L
Authority
NO
Norway
Prior art keywords
healing
bone
sars
regeneration
mammal
Prior art date
Application number
NO883127A
Other languages
English (en)
Norwegian (no)
Other versions
NO883127D0 (no
Inventor
Harold C Antoniades
Ray C Williams
Samuel E Lynch
Original Assignee
Inst Of Molecular Biology
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Molecular Biology, Harvard College filed Critical Inst Of Molecular Biology
Publication of NO883127D0 publication Critical patent/NO883127D0/no
Publication of NO883127L publication Critical patent/NO883127L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO883127A 1986-11-14 1988-07-13 Heling av saar og regenerering av ben. NO883127L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93076286A 1986-11-14 1986-11-14
PCT/US1987/002975 WO1988003409A1 (fr) 1986-11-14 1987-11-13 Guerison de plaies et regeneration d'os

Publications (2)

Publication Number Publication Date
NO883127D0 NO883127D0 (no) 1988-07-13
NO883127L true NO883127L (no) 1988-09-12

Family

ID=25459724

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883127A NO883127L (no) 1986-11-14 1988-07-13 Heling av saar og regenerering av ben.

Country Status (15)

Country Link
EP (1) EP0289584B1 (fr)
JP (1) JPH01500199A (fr)
KR (1) KR960005708B1 (fr)
CN (1) CN1027346C (fr)
AT (1) ATE88899T1 (fr)
AU (1) AU600069B2 (fr)
DE (1) DE3785758T2 (fr)
DK (1) DK175889B1 (fr)
IE (1) IE60517B1 (fr)
MX (1) MX170454B (fr)
NO (1) NO883127L (fr)
NZ (1) NZ222551A (fr)
OA (1) OA09159A (fr)
WO (1) WO1988003409A1 (fr)
ZA (1) ZA878566B (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849407A (en) * 1986-08-13 1989-07-18 Zymogenetics, Inc. Biologically active mosaic proteins
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
ZA9010332B (en) * 1989-12-22 1991-08-28 Ciba Geigy Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
WO1991015231A1 (fr) * 1990-04-10 1991-10-17 Institute Of Molecular Biology, Inc. Cicatrisation de plaies
ES2178633T3 (es) * 1990-05-30 2003-01-01 Harvard College Utilizacion concomitante del factor -i de crecimiento similar a insulina (en lo sucesivo "fci-i") y el factor de crecimiento transformante beta (en la sucesivo "fct-beta") para la fabricacion de un medicamento para la regeneracion de huesos en mamiferos.
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
WO1993008825A1 (fr) * 1991-11-04 1993-05-13 Zymogenetics, Inc. Formulation d'un gel de fcdp
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
JPH06510065A (ja) * 1992-06-08 1994-11-10 カイロン　コーポレーション 成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
CN1055023C (zh) * 1993-01-03 2000-08-02 周至譓 伤口护理剂
EP1217067A2 (fr) 1994-07-12 2002-06-26 Human Genome Sciences, Inc. Facteur de croissance 2 de tissu conjonctif
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
ES2293137T3 (es) 1995-10-11 2008-03-16 Novartis Vaccines And Diagnostics, Inc. Combinacion de pdgf, kgf,igf e igfbp para curacion de heridas.
EP1935901A1 (fr) 1996-12-13 2008-06-25 Novartis Vaccines and Diagnostics, Inc. Analyse et séparation de protéines PDGF
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7241874B2 (en) 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR20080084808A (ko) 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
WO2007092622A2 (fr) 2006-02-09 2007-08-16 Biomimetic Therapeutics, Inc. Compositions et méthodes pour le traitement d'os
CA2656278C (fr) 2006-06-30 2016-02-09 Biomimetic Therapeutics, Inc. Compositions et procedes destines au traitement de lesions de la coiffe des rotateurs
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US8106008B2 (en) 2006-11-03 2012-01-31 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
JP5864106B2 (ja) 2008-02-07 2016-02-17 バイオミメティック セラピューティクス， エルエルシー 仮骨延長のための組成物および方法
AU2009291828C1 (en) 2008-09-09 2016-03-17 Biomimetic Therapeutics, Llc Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
CA2790403C (fr) 2010-02-22 2019-08-27 Biomimetic Therapeutics, Inc. Compositions de facteur de croissance derive des plaquettes et procedes pour le traitement de tendinopathies
CN102397534B (zh) * 2010-09-07 2013-10-23 中国人民解放军总医院 胰岛素在制备促进颌骨组织愈合的药物中的用途
WO2013077641A1 (fr) * 2011-11-22 2013-05-30 (주)아모레퍼시픽 Agent d'amélioration de la réparation de la peau contenant des facteurs de croissance
CA2962954A1 (fr) 2014-10-14 2016-04-21 Samuel Lynch Compositions pour le traitement de plaies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor

Also Published As

Publication number Publication date
DK393288D0 (da) 1988-07-14
DE3785758T2 (de) 1993-08-05
EP0289584A4 (fr) 1990-01-08
CN87101250A (zh) 1988-06-08
OA09159A (en) 1992-03-31
DK175889B1 (da) 2005-05-30
JPH01500199A (ja) 1989-01-26
NO883127D0 (no) 1988-07-13
KR960005708B1 (ko) 1996-05-01
WO1988003409A1 (fr) 1988-05-19
AU600069B2 (en) 1990-08-02
ATE88899T1 (de) 1993-05-15
EP0289584B1 (fr) 1993-05-05
IE873075L (en) 1988-05-14
EP0289584A1 (fr) 1988-11-09
NZ222551A (en) 1989-11-28
CN1027346C (zh) 1995-01-11
JPH0581569B2 (fr) 1993-11-15
AU8328987A (en) 1988-06-01
MX170454B (es) 1993-08-24
DE3785758D1 (de) 1993-06-09
IE60517B1 (en) 1994-07-27
ZA878566B (en) 1989-07-26
DK393288A (da) 1988-09-13
KR890700033A (ko) 1989-03-02

Similar Documents

Publication Publication Date Title
NO883127D0 (no) Heling av saar og regenerering av ben.
ATE109352T1 (de) Heilung von wunden.
CA2040410A1 (fr) Compositions pour traiter des plaies contenant de l'interleukine 1 et un facteur de croissance
AU7191487A (en) Wound healing composition
EP0295721A3 (en) Promotion of healing of meniscal tissue
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
IT8547664A0 (it) Composizione acquosa per il trattamento del cavo orale
NO880950L (no) Fremstilling av oksygen med hoey renhet.
ZA889594B (en) Wound healing
BR8801303A (pt) Composicao vedadora adesiva de cura anaerobica
KR890007782A (ko) 산성 기체 흡수제 조성물
DE69031218D1 (de) Wundheilung
EP0702518A4 (fr) Traitement des maladies vasculaires degeneratives par modulation de l'activite ou de la production d'oxyde nitrique endogene
ZA883744B (en) Promotion of healing of meniscal tissue
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
DE69133087T2 (de) Kombination aus IGF-I und TGF-beta zur Knochenregenerierung
AU7670687A (en) Improvements in or relating to the treatment of occlusive vascular diseases
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
DE3852528D1 (de) Herstellung von Polyarylensulfiden hoher Reinheit.
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU1541088A (en) Composition for the treatment of the epiderm
ATE51520T1 (de) Kosmetikum.
AU7422387A (en) Tumor necrosis factor alpha as treatment for infectious diseases
ZA877303B (en) Pharmaceutical composition for the treatment of high blood pressure
BR8700602A (pt) Cura magnetica